There’s a reason Denmark has had some of the earliest and broadest access to GLP-1 medications in Europe. Novo Nordisk is a Danish company, and that matters. Here’s what GLP-1 access actually looks like for someone in Denmark in 2026.
The Novo Nordisk Advantage
Ozempic and Wegovy are manufactured by Novo Nordisk, a company headquartered in Bagsværd, just outside Copenhagen. It is Denmark’s largest company by market cap and one of the most significant pharmaceutical operations in the world.
That origin story has practical implications for access in Denmark. Lægemiddelstyrelsen (the DKMA, Denmark’s medicines agency) approved both products among the earliest in Europe. Physician familiarity is high. Pharmacy stock has been more reliable in Denmark than in many other European countries during supply-constrained periods. And awareness among both patients and prescribers is higher than almost anywhere else.
On Ozempic? Regimen’s Ozempic app logs the shot in one tap, reminds you before the next one, and ties your side effects and weight to each dose step.
What’s Approved and Available
| Medication | Active ingredient | Approved for | Coverage |
|---|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes | Sygesikring for T2D patients |
| Wegovy | Semaglutide 2.4mg | Obesity (BMI 30+ or 27+ with comorbidity) | No general reimbursement |
| Mounjaro | Tirzepatide | Type 2 diabetes | Growing availability, coverage evolving |
Ozempic: Coverage for Type 2 Diabetes
For T2D patients, Ozempic is well covered under the Danish Sygesikring system. Prescription through your GP (praktiserende læge) or endocrinologist/diabetologist. Standard T2D management protocol. This is a well-established pathway in Denmark, and prescribers at every level of the system are familiar with it.
Wegovy: Weight Management Access
Wegovy is where the coverage picture gets more nuanced. Denmark was among the first European countries where Wegovy launched, and it is available. Wegovy is not on the general reimbursement list: Lægemiddelstyrelsen refused general tilskud in 2022 and again in 2025. Your doctor can apply for individual reimbursement (enkelttilskud), decided case by case.
Out-of-pocket cost for Wegovy in Denmark without reimbursement is the official pharmacy price on medicinpriser.dk: DKK 1,284.25 a pen at 0.25, 0.5 or 1 mg, DKK 1,790.40 at 1.7 mg and DKK 2,296.55 at 2.4 mg (price period 12 to 25 October 2026; prices are reset every two weeks). One pen holds four weekly doses, so about a month.
Last checked: October 2026.
Ask your doctor whether an enkelttilskud application is worth making before assuming private cost is your only option.
Mounjaro in Denmark
Mounjaro (tirzepatide) is approved in Denmark and growing in availability through 2025 and 2026. For T2D patients, it is an option your prescriber can discuss. Coverage under Sygesikring for T2DM is evolving, so ask your endocrinologist specifically about current reimbursement status at your consultation.
How to Get Started
For T2D: your GP can initiate Ozempic directly. Bring your HbA1c, fasting glucose, and cardiovascular history. The conversation is routine in Denmark.
For weight management: your GP is the right starting point. Reimbursement needs an enkelttilskud application from your doctor. If you want faster access without pursuing the referral, private prescription through a private GP or clinic is straightforward.
Use the GLP-1 Dose Calculator to map out your titration schedule from starting dose through maintenance. GLP-1 titration runs across 4 to 5 months on the standard Wegovy schedule, and tracking each tier helps you understand what’s driving any response.
If you are still choosing an app, the best GLP-1 tracker apps comparison covers the free tiers and what each one actually tracks.
Related Denmark Guides
If you’re also on TRT or exploring it alongside GLP-1, see the Denmark TRT Guide. For peptides in Denmark, see the Denmark Peptides Guide.
Frequently Asked Questions
Is Ozempic covered by the Danish public health system?
Yes. Ozempic is covered under the Danish Sygesikring system for T2D patients meeting standard prescribing criteria. Your GP or diabetologist can prescribe it on a reimbursed basis as part of standard type 2 diabetes management.
Is Wegovy available in Denmark?
Yes. Wegovy is approved by Lægemiddelstyrelsen and available in Denmark. It is not on the general reimbursement list; a doctor can apply for individual reimbursement (enkelttilskud). Otherwise you pay the official pharmacy price: DKK 1,284.25 to 2,296.55 a pen, about a month (medicinpriser.dk, last checked October 2026).
Is Ozempic covered by the Danish public health system? Yes. Ozempic is covered under Sygesikring for T2D patients meeting standard prescribing criteria. Your GP or diabetologist can prescribe it on a reimbursed basis as part of T2D management.
Is Wegovy available in Denmark? Yes. Wegovy is approved and available in Denmark. It is not generally reimbursed; a doctor can apply for enkelttilskud. Otherwise you pay the official pharmacy price: DKK 1,284.25 to 2,296.55 a pen, about a month.
How much does Wegovy cost in Denmark without coverage?
DKK 1,284.25 a pen at 0.25, 0.5 or 1 mg, DKK 1,790.40 at 1.7 mg and DKK 2,296.55 at 2.4 mg, at the official pharmacy price (medicinpriser.dk, last checked October 2026). One pen holds four weekly doses, so about a month.
Is Mounjaro (tirzepatide) available in Denmark?
Yes. Mounjaro is approved in Denmark and growing in availability. For T2DM patients, ask your endocrinologist about current reimbursement status, as coverage is evolving as of 2026.
Why does Denmark have such strong GLP-1 access? Novo Nordisk, the manufacturer of Ozempic and Wegovy, is a Danish company headquartered near Copenhagen. Danish regulatory approval was among the earliest in Europe. Prescriber familiarity and pharmacy availability are both higher in Denmark than in most comparable markets.
This article is for informational purposes only and does not constitute medical advice. Discuss all treatment decisions with your healthcare provider.
Ready to track your GLP-1?
- Smart reminders so you never miss a dose
- Track weight, photos, and progress over time
- Medication level curves for 150+ compounds
